NCT02778477View on ClinicalTrials.gov

Topical Multiple Ascending Dose Study for PF-06423264

PHASE1TerminatedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 23, 2016

Primary Completion Date

May 23, 2017

Study Completion Date

May 23, 2017

Conditions
Normal Healthy
Interventions
DRUG

PF-06423264

Multiple ascending dose of PF-06423264

OTHER

Placebo

Multiple dose of placebo

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02778477 - Topical Multiple Ascending Dose Study for PF-06423264 | Biotech Hunter | Biotech Hunter